ZIMLAB quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Zim Laboratories Ltd reported sales of ₹94.18 Cr, operating profit of ₹2.45 Cr (OPM 2.6%) and net profit of ₹-4.02 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
ZIMLAB quarterly results (₹ Cr)
Metric
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
92.14
96.33
108.73
71.76
88.71
108.66
105.27
94.18
YoY Sales growth
7.35
0.04
-7.75
-12.3
-3.72
12.8
-3.18
31.24
Expenses
82.61
84.77
94.13
67.51
82.95
95.85
98.08
91.73
Operating Profit
9.53
11.56
14.6
4.25
5.76
12.81
7.19
2.45
OPM
10.34%
12%
13.43%
5.92%
6.49%
11.79%
6.83%
2.6%
Other Income
1.32
1.75
1.71
1.48
2.04
1.7
6.16
0.99
Interest
2.89
2.73
2.91
3.3
3.16
3.43
3.31
3.64
Depreciation
5
4.88
5.29
4.86
4.98
5.03
5.1
5.37
Profit before tax
2.96
5.7
8.11
-2.43
-0.34
6.05
4.94
-5.57
Tax
19.59%
30%
39.7%
-22.63%
23.53%
27.27%
24.29%
-28.01%
Net Profit
2.38
4
4.88
-1.87
-0.42
4.4
3.74
-4.02
EPS in Rs
0.49
0.82
1
-0.38
-0.09
0.9
0.7
-0.75
ZIMLAB profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
333
399
367
379
374
397
Sales growth
9
20
-8
3
-1
8
Expenses
292
347
326
335
344
369
Operating Profit
41
52
41
44
30
28
OPM
12%
13%
11%
12%
8%
7%
Other Income
4
6
5
6
11
11
Interest
8
6
7
11
13
14
Depreciation
16
17
16
20
20
20
Profit before tax
21
35
24
18
8
5
Tax
31%
31%
27%
32%
29%
-
Net Profit
15
24
17
12
6
4
EPS in Rs
2.99
5.01
3.54
2.5
1.09
0.76
Dividend Payout
0%
0%
0%
0%
0%
-
ZIMLAB balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
49
49
49
49
54
Reserves
152
190
204
203
243
Borrowings
62
112
118
121
127
Other Liabilities
79
96
102
94
116
Total Liabilities
342
447
472
467
539
Fixed Assets
109
161
164
187
162
CWIP
27
42
70
46
96
Investments
0
0
0
0
0
Other Assets
206
244
237
234
282
Total Assets
342
447
472
467
539
ZIMLAB cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
49
38
16
41
50
Cash from Investing Activity
-14
-35
-73
-40
-55
Cash from Financing Activity
-33
1
60
-9
28
Net Cash Flow
2
3
3
-8
23
Free Cash Flow
34
1
-57
1
11
CFO/OP
121%
86%
46%
92%
177%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit